MA56551A - Procédés et intermédiaires pour la production de composés de diazaspiro-lactame - Google Patents
Procédés et intermédiaires pour la production de composés de diazaspiro-lactameInfo
- Publication number
- MA56551A MA56551A MA056551A MA56551A MA56551A MA 56551 A MA56551 A MA 56551A MA 056551 A MA056551 A MA 056551A MA 56551 A MA56551 A MA 56551A MA 56551 A MA56551 A MA 56551A
- Authority
- MA
- Morocco
- Prior art keywords
- diazaspirolactam
- intermediates
- compounds
- production
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962865840P | 2019-06-24 | 2019-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA56551A true MA56551A (fr) | 2022-04-27 |
Family
ID=74060351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA056551A MA56551A (fr) | 2019-06-24 | 2020-06-23 | Procédés et intermédiaires pour la production de composés de diazaspiro-lactame |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12215114B2 (fr) |
| EP (2) | EP4484431A3 (fr) |
| CN (2) | CN120004904A (fr) |
| ES (1) | ES2991258T3 (fr) |
| MA (1) | MA56551A (fr) |
| TW (1) | TWI887245B (fr) |
| WO (1) | WO2020263848A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220267341A1 (en) * | 2019-06-24 | 2022-08-25 | Naurex Inc. | Solid forms of tert-butyl (s)-2((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them |
| EP4484431A3 (fr) | 2019-06-24 | 2025-03-26 | Naurex Inc. | Procédés et intermédiaires pour la production de composés de diazaspiro lactame |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5688787A (en) * | 1991-07-23 | 1997-11-18 | Schering Corporation | Substituted β-lactam compounds useful as hypochlesterolemic agents and processes for the preparation thereof |
| BRPI0918868B8 (pt) * | 2008-09-18 | 2021-05-25 | Naurex Inc | compostos moduladores do receptor de nmda e composições compreendendo os mesmos |
| US9758525B2 (en) * | 2013-01-29 | 2017-09-12 | Aptinyx Inc. | Spiro-lactam NMDA receptor modulators and uses thereof |
| EP2951186B1 (fr) * | 2013-01-29 | 2018-07-25 | Aptinyx Inc. | Modulateurs spirolactames d'un récepteur nmda et leurs utilisations |
| KR102410989B1 (ko) * | 2013-01-29 | 2022-06-17 | 앱티닉스 인크. | 스피로-락탐 nmda 수용체 조절인자 및 그의 용도 |
| PE20151416A1 (es) | 2013-01-29 | 2015-10-10 | Naurex Inc | Moduladores de receptores nmda de espiro-lactama y sus usos |
| US20140238699A1 (en) | 2013-02-22 | 2014-08-28 | Vetco Gray Inc. | Wellhead annulus seal having a wickered surface |
| WO2017201285A1 (fr) * | 2016-05-19 | 2017-11-23 | Aptinyx Inc. | Modulateurs spirolactames des récepteurs nmda et leurs utilisations |
| PE20190174A1 (es) * | 2016-05-19 | 2019-02-01 | Aptinyx Inc | Moduladores del receptor espiro-lactama n-metil-d-aspartato y usos de los mismos |
| WO2019152696A1 (fr) | 2018-01-31 | 2019-08-08 | Aptinyx Inc. | Spiro-lactame modulateur de récepteurs nmda et leurs utilisations |
| US20220267341A1 (en) * | 2019-06-24 | 2022-08-25 | Naurex Inc. | Solid forms of tert-butyl (s)-2((2s,3r)-1-amino-3-hydroxy-1-oxobu tan-2-yl)-1-oxo-2, 5-diazaspiro [3.4] octan e-5-carboxylate and methods of preparing them |
| EP4484431A3 (fr) | 2019-06-24 | 2025-03-26 | Naurex Inc. | Procédés et intermédiaires pour la production de composés de diazaspiro lactame |
-
2020
- 2020-06-23 EP EP24195355.3A patent/EP4484431A3/fr active Pending
- 2020-06-23 EP EP20832011.9A patent/EP3986400B1/fr active Active
- 2020-06-23 CN CN202510130487.3A patent/CN120004904A/zh active Pending
- 2020-06-23 MA MA056551A patent/MA56551A/fr unknown
- 2020-06-23 ES ES20832011T patent/ES2991258T3/es active Active
- 2020-06-23 WO PCT/US2020/039164 patent/WO2020263848A1/fr not_active Ceased
- 2020-06-23 TW TW109121351A patent/TWI887245B/zh active
- 2020-06-23 CN CN202080059426.8A patent/CN114269338B/zh active Active
- 2020-06-23 US US17/621,905 patent/US12215114B2/en active Active
-
2024
- 2024-12-20 US US18/990,702 patent/US20250243211A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3986400B1 (fr) | 2024-08-21 |
| US12215114B2 (en) | 2025-02-04 |
| WO2020263848A1 (fr) | 2020-12-30 |
| US20220259217A1 (en) | 2022-08-18 |
| EP4484431A3 (fr) | 2025-03-26 |
| CN120004904A (zh) | 2025-05-16 |
| EP3986400A4 (fr) | 2023-05-17 |
| EP3986400A1 (fr) | 2022-04-27 |
| EP4484431A2 (fr) | 2025-01-01 |
| US20250243211A1 (en) | 2025-07-31 |
| CN114269338A (zh) | 2022-04-01 |
| TWI887245B (zh) | 2025-06-21 |
| CN114269338B (zh) | 2025-02-18 |
| ES2991258T3 (es) | 2024-12-03 |
| EP3986400C0 (fr) | 2024-08-21 |
| TW202110852A (zh) | 2021-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3359164A4 (fr) | Composés et procédés pour moduler l'expression de l'angiotensinogène | |
| EP3652303A4 (fr) | Plate-forme microfluidique pour la production rapide d'organoïdes/sphéroïdes pour criblage de composés | |
| MA53219A (fr) | Nouveaux composés hétérocycliques en tant qu'inhibiteurs de monoacylglycérol lipase | |
| MA54946A (fr) | Procédés et composés | |
| MA50169A (fr) | Procédé de production d'un électrocatalyseur | |
| EP3665142A4 (fr) | Procédés à flux continu pour la fabrication de composés bicycliques | |
| MA46791A (fr) | Composés et procédés pour réduire l'expression d'atxn3 | |
| EP3615657A4 (fr) | Appareil, procédés et composition pour la synthèse de composés cannabinoïdes | |
| EP3678700A4 (fr) | Composés pour la réduction de la viscosité de formulations biologiques | |
| EP3611171A4 (fr) | Procédé de synthèse d'éliglustat et de composés intermédiaires de celui-ci | |
| IL285339A (en) | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof | |
| IL284374A (en) | Methods of producing ustekinumab | |
| HUE064888T2 (hu) | Eljárás alkoxilátok elõállítására | |
| SG11202010677XA (en) | Methods for the production of methacrylates | |
| EP3889374A4 (fr) | Procédé de construction d'immeubles | |
| EP3648773A4 (fr) | Composés et procédés pour l'administration transmembranaire de molécules | |
| HUE062863T2 (hu) | Eljárás szulfid szilárd elektrolit elõállítására | |
| EP3901123A4 (fr) | Procédé de production de fluoro-éthane et procédé de production d'une fluoro-oléfine | |
| IL282387A (en) | Carbonation of fiber cement products | |
| EP3927685A4 (fr) | Procédé de synthèse de composés diamide anthranilique et intermédiaires associés | |
| EP3947409A4 (fr) | Production biosynthétique d'udp-rhamnose | |
| EP3903987A4 (fr) | Procédé d'assemblage | |
| HUE058990T2 (hu) | Folyamatos eljárás trazodon elõállítására | |
| MA56551A (fr) | Procédés et intermédiaires pour la production de composés de diazaspiro-lactame | |
| EP4003962A4 (fr) | Procédé de synthèse de composés de pyrazolidinone |